Early Human Development, Journal Year: 2024, Volume and Issue: 200, P. 106167 - 106167
Published: Nov. 28, 2024
Language: Английский
Pediatric Research, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 15, 2025
Language: Английский
Citations
0
Biomedicines, Journal Year: 2025, Volume and Issue: 13(3), P. 670 - 670
Published: March 9, 2025
Background: Patent ductus arteriosus (PDA) in preterm infants presents a significant challenge neonatal care, marked by ongoing debates about its definition, diagnosis, treatment options, and effects on patient outcomes. Plasma biomarkers assess mediators involved PDA closure hemodynamic responses, assisting identifying newborns at higher risk of developing potentially serious conditions. The purpose this review was to investigate the relationship between various plasma used evaluate diagnose ductal patency during perinatal life, as outlined relevant literature. Methods: We conducted an electronic search National Library Medicine (MEDLINE)/PubMed Web Science for studies published up December 2024, including prospective, retrospective, cohort, cross-sectional studies, well reviews meta-analyses. keywords included “preterm infant”, “persistent arteriosus”, “patent “PDA”, “neonatal biomarkers”, “cardiac “vasoactive biomarkers”. Results: Out 813 identified articles, 85 were our cardiac biomarkers: Natriuretic peptides (NPs), Cardiac troponin T (cTnT), vasoactive (Mid-regional pro-adrenomedullin (MR-proADM), Endothelin-1 (ET-1), Copeptin, Isoprostanes (IPs)), inflammatory (Interleukin-6 (IL-6), IL-8, IL-10, Growth Differentiation Factor 15 (GDF-15), Monocyte Chemoattractant Protein-1 (MCP-1/CCL2), Macrophage Inflammatory Protein-1α (MIP-1α/CCL3)) relation PDA. Conclusions: Even if research shows strong correlation specific echocardiographic parameters patients with PDA, clinical judgment must take these evaluations into account, particularly when determining whether treat Future should focus investigating new associated underlying mechanisms dynamics infants.
Language: Английский
Citations
0
Zeitschrift für Geburtshilfe und Neonatologie, Journal Year: 2025, Volume and Issue: 229(03), P. e86 - e87
Published: May 1, 2025
Citations
0
Journal of Perinatology, Journal Year: 2024, Volume and Issue: 44(10), P. 1402 - 1408
Published: July 12, 2024
Language: Английский
Citations
3
Journal of Cardiovascular Development and Disease, Journal Year: 2024, Volume and Issue: 11(5), P. 132 - 132
Published: April 23, 2024
(1) Background: To identify reasons for the persistence of surgical ligation patent ductus arteriosus (PDA) in premature infants after 2019 Food and Drug Administration (FDA) approval transcatheter device closure; (2) Methods: We performed a 10-year (2014–2023) single-institution retrospective study (<37 weeks) compared clinical characteristics neonatal morbidities between neonates that underwent before (epoch 1) 2) FDA (3) Results: identified 120 (n = 94 before, n 26 approval). Unfavorable PDA morphology, active infection, recent abdominal pathology were most common over occlusion epoch 2. There no differences demographics, age at closure, or outcomes who received two epochs; (4) Conclusions: Despite increasing trends closure infants, persists due to unfavorable ductal pathology.
Language: Английский
Citations
1
American Journal of Perinatology, Journal Year: 2024, Volume and Issue: 42(01), P. 043 - 051
Published: May 31, 2024
Prostaglandins (PGs) play a major role in maintaining patency of the ductal arteriosus (DA). Pulmonary 15-hydroxyprostaglandin dehydrogenase (PGDH), which is ecoded by hydroxyprostaglandin (
Language: Английский
Citations
0
Early Human Development, Journal Year: 2024, Volume and Issue: 200, P. 106167 - 106167
Published: Nov. 28, 2024
Language: Английский
Citations
0